Selective laser trabeculoplasty (SLT) as replacement therapy in glaucoma patients

Glaucoma is a very common chronic disease. Selective laser trabeculoplasty (SLT) has the advantage of eliminating the side effects that are very common after using anti-glaucoma eye drops. We aim to investigate several aspects of SLT

1. does pseudophakia influence intra ocular pressure (IOP) lowering effect of SLT?

2. the effect of SLT relies on an inflammatory reaction. Anti-inflammatory therapy is often used immediately following SLT, does this influence the IOP lowering effect or the side effects after SLT?

3. anti-glaucoma eye drops have a lot of side effects. Does SLT improve quality of life by reducing number of eye medications?

4. is there a significant difference in IOP lowering effect of SLT in low, normal or high tension glaucoma?

start, 1 hour, 1 week, 1, 3, 6 and 12 months after SLT

1,Randomization decides whether patients receive SLT or continue on drops.

2,In those to receive SLT, randomization decides whether indomethacin or dexamethasone drops are given after SLT.

3,SLT is applied in both eyes, randomization decides in which eye the anti-inflammatory therapy (indomethacin or dexamethasone) is given, we start SLT always at the right eye.

4, SLT is performed, right eye first, the week after that, the other eye is treated. Eye that does not receive anti-inflammatory therapy is control eye.